These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7127293

  • 21. Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.
    Miller AA, Moore EC, Hurlbert RB, Benvenuto JA, Loo TL.
    Cancer Res; 1983 Jun; 43(6):2565-70. PubMed ID: 6189583
    [Abstract] [Full Text] [Related]

  • 22. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW, Jayaram HN, Cooney DA.
    Adv Enzyme Regul; 1982 Jun; 20():57-73. PubMed ID: 7113804
    [Abstract] [Full Text] [Related]

  • 23. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2018 Jun; 37(6):329-339. PubMed ID: 29723133
    [Abstract] [Full Text] [Related]

  • 24. Relationship between ribo- and deoxyribonucleotide concentrations and biological parameters in cultured Chinese hamster ovary cells.
    Hunting D, Henderson JF.
    Biochem Pharmacol; 1982 Mar 15; 31(6):1109-15. PubMed ID: 7082365
    [Abstract] [Full Text] [Related]

  • 25. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
    Cory AH, Hickerson DH, Cory JG.
    Anticancer Res; 2000 Mar 15; 20(6B):4171-8. PubMed ID: 11205244
    [Abstract] [Full Text] [Related]

  • 26. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis.
    Moore EC.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3313-6. PubMed ID: 7150357
    [Abstract] [Full Text] [Related]

  • 27. Effect of N-phosphonacetyl-L-aspartate and D-glucosamine on the incorporation of 5-fluorouridine into normal tissues and an adenocarcinoma in the rat.
    Erichsen C, Christensson PI, Jakobsson B, Eriksson G, Yngner T, Jönsson PE, Stenram U.
    Anticancer Res; 1987 Oct 15; 7(1):77-80. PubMed ID: 3566186
    [Abstract] [Full Text] [Related]

  • 28. An overview of the clinical pharmacology of N-phosphonacetyl-L-aspartate (PALA), a new antimetabolite.
    Erlichman C.
    Recent Results Cancer Res; 1980 Oct 15; 74():65-71. PubMed ID: 7444150
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
    Ardalan B, Glazer RI, Kensler TW, Jayaram HN, Van Pham T, Macdonald JS, Cooney DA.
    Biochem Pharmacol; 1981 Aug 01; 30(15):2045-9. PubMed ID: 7295324
    [No Abstract] [Full Text] [Related]

  • 33. Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells.
    Jacobsen LB, Putnam JE, Sawick DP, Cassady JM, Morré DJ.
    Life Sci; 1988 Aug 01; 42(8):913-8. PubMed ID: 3343891
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.